Best Practices in Biotechnology Business Development: Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property

These best practices provide a framework upon which to understand critical issues in biotechnology business development. Experts from a wide range of disciplines have composed best practices based on their experiences and expertise, creating a vital toolbox covering a broad spectrum of topics. These best practices will enable you develop a better understanding of the key elements in these operations and empower you to better manage their implementation.

Yali Friedman holds a doctorate in biochemistry and is author of Building Biotechnology, a widely-used course text in biotechnology programs. He regularly guest lectures for the Johns Hopkins MS/MBA program in biotechnology, teaching classes on the business of biotechnology and has published papers on diverse topics such as strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, entrepreneurship in biotechnology, and new paradigms in technology- based economic development.

Yali is also managing editor of the Journal of Commercial Biotechnology and serves on the science advisory board of Chakra Biotech and the editorial advisory boards of the Biotechnology Journal and Open Biotechnology Journal.

Yali has a long history in biotechnology media, having created a Forbes "Best of the Web"-rated web site on the biotechnology industry for a NY Times company and managed it for many years. His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television; BiotechBlog.com; and, DrugPatentWatch.com, a pharmaceutical industry competitive intelligence service.